Phanes Therapeutics

Developer of therapeutic solutions for treating immuno-oncology and eye disease

placeSan Diego, California, United States calendar_todayFounded 2016 groups28 employees language phanesthera.com

Innovation

23 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 942 times.

YearFilings
20199
202012
202115
202215
20238
202414
202512
20261

Social engagement

Social engagement: 5.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Sequoia Capital China.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

22 Jun 2026
Milestone
regulatory
17 Jun 2026
Event
BIO2026
2 Jun 2026
Event
ASCO26
Coming soon